Microbial Hemeprotein to Increase Intestinal Mucin Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments and compositions do not effectively promote mucin production in the intestinal mucosa to prevent or treat enteritis, which is often caused by bacterial or viral infections that degrade mucins and facilitate bacterial invasion, leading to inflammation.
Innovation Solution
The use of microbial hemeproteins, derived from microorganisms with high heme iron-producing capability, to increase mucin production and strengthen the intestinal mucosal layer, thereby enhancing the intestinal barrier against harmful substances.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used, then existing therapeutic approaches are maintained, but mucin production is not effectively promoted and enteritis prevention/treatment is insufficient
Solution Approach 1:
The patent applies parameter changes by introducing microbial hemeprotein as a new substance parameter that directly stimulates mucin production. The hemeprotein contains heme iron which acts as a signaling molecule to upregulate MUC2 gene expression and mucin synthesis in goblet cells, thereby changing the biochemical parameter landscape to promote protective mucus layer formation and enhance enteritis prevention effectiveness
Solution Approach 2:
The patent uses microbial hemeprotein as an intermediary substance that mediates between the administered composition and the intestinal epithelial cells. The hemeprotein acts as a signaling intermediary that triggers intracellular pathways leading to increased mucin production, serving as a bridge between external treatment and internal physiological response
2Strength
If microbial hemeprotein is used, then mucin production and intestinal barrier function are enhanced, but new substance introduction requires validation
Solution Approach 1:
The patent employs composite materials by formulating microbial hemeprotein in combination with pharmaceutical carriers or excipients to create a composite composition. The hemeprotein itself is a composite structure consisting of heme iron prosthetic group bound to protein, and when formulated with carriers, it becomes a multi-component composite that enhances delivery, stability, and bioavailability while maintaining the core function of stimulating mucin production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Microbial hemeproteins enhance mucin production, improving the intestinal mucosal barrier's protective function, preventing and treating enteritis by increasing goblet cell expression and mucin content, particularly effective in conditions like ulcerative colitis and irritable bowel syndrome.
Implementation Method 1
heme iron, which has a high absorption rate in vivo and causes no side effects, is utilized as a valuable source of iron, and in particular, heme iron produced by microorganisms having heme iron-producing capability is employed in the form of microbial hemoprotein
Data Source
AI summary
The present disclosure relates to a use of microbial hemeproteins for promoting mucin production, in particular, for improving intestinal immunity and treating or preventing enteritis by increasing production of mucin, which forms the intestinal mucus layer.